Home
/
INTELLIGENT BIO SOLUTIONS INC.
/
Financials
/
Quarterly
INTELLIGENT BIO SOLUTIONS INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that INTELLIGENT BIO SOLUTIONS INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Mar 31, 2025
$902.1K
May 13, 2025
Q2
2025
Dec 31, 2024
$741.1K
Feb 13, 2025
Q1
2025
Sep 30, 2024
$998.4K
Nov 7, 2024
Q3
2025
Mar 31, 2024
$907.6K
May 13, 2025
Q2
2025
Dec 31, 2023
$917.3K
Feb 13, 2025
Q1
2025
Sep 30, 2023
$906.0K
Nov 7, 2024
Q2
2022
Dec 31, 2021
$177.8K
Feb 11, 2022
Q3
2021
Mar 31, 2021
$34.3K
May 13, 2021
Q2
2022
Dec 31, 2020
$283.0K
Feb 11, 2022
Q1
2022
Sep 30, 2020
$55.4K
Nov 12, 2021
Q3
2021
Mar 31, 2020
($1.5K)
May 13, 2021
Q2
2021
Dec 31, 2019
($798)
Feb 12, 2021
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$896.8K
Feb 12, 2026
Q1
2026
Sep 30, 2025
$1.11M
Nov 12, 2025
Q3
2025
Mar 31, 2025
$728.9K
May 13, 2025
Q2
2026
Dec 31, 2024
$607.5K
Feb 12, 2026
Q1
2026
Sep 30, 2024
$872.3K
Nov 12, 2025
Q3
2025
Mar 31, 2024
$823.8K
May 13, 2025
Q2
2025
Dec 31, 2023
$764.1K
Feb 13, 2025
Q1
2025
Sep 30, 2023
$796.1K
Nov 7, 2024
Q3
2024
Mar 31, 2023
$457.1K
May 8, 2024
Q2
2024
Dec 31, 2022
$356.7K
Feb 9, 2024
Q1
2023
Sep 30, 2022
$311.3K
Nov 14, 2022
Q3
2022
Mar 31, 2022
$192.5K
May 16, 2022
Q3
2022
Mar 31, 2021
$34.3K
May 16, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($2.68M)
Feb 12, 2026
Q1
2026
Sep 30, 2025
($2.98M)
Nov 12, 2025
Q3
2025
Mar 31, 2025
($2.54M)
May 13, 2025
Q2
2026
Dec 31, 2024
($2.25M)
Feb 12, 2026
Q1
2026
Sep 30, 2024
($2.69M)
Nov 12, 2025
Q3
2025
Mar 31, 2024
($2.98M)
May 13, 2025
Q2
2025
Dec 31, 2023
($1.97M)
Feb 13, 2025
Q1
2025
Sep 30, 2023
($2.43M)
Nov 7, 2024
Q3
2024
Mar 31, 2023
($6.34M)
May 8, 2024
Q2
2024
Dec 31, 2022
($420.6K)
Feb 9, 2024
Q1
2024
Sep 30, 2022
($1.21M)
Nov 8, 2023
Q3
2023
Mar 31, 2022
($1.34M)
May 11, 2023
Q2
2023
Dec 31, 2021
($3.46M)
Feb 14, 2023
Q1
2023
Sep 30, 2021
($1.43M)
Nov 14, 2022
Q3
2022
Mar 31, 2021
($3.13M)
May 16, 2022
Q2
2022
Dec 31, 2020
($1.98M)
Feb 11, 2022
Q1
2022
Sep 30, 2020
($1.07M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($1.84M)
Feb 12, 2021
Q3
2021
Mar 31, 2020
($112.6K)
May 13, 2021
Q2
2021
Dec 31, 2019
($1.84M)
Feb 12, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($2.64M)
Feb 12, 2026
Q1
2026
Sep 30, 2025
($3.00M)
Nov 12, 2025
Q3
2025
Mar 31, 2025
($2.55M)
May 13, 2025
Q2
2026
Dec 31, 2024
($2.26M)
Feb 12, 2026
Q1
2026
Sep 30, 2024
($2.73M)
Nov 12, 2025
Q3
2025
Mar 31, 2024
($2.95M)
May 13, 2025
Q2
2025
Dec 31, 2023
($1.99M)
Feb 13, 2025
Q1
2025
Sep 30, 2023
($2.53M)
Nov 7, 2024
Q3
2024
Mar 31, 2023
($6.54M)
May 8, 2024
Q2
2024
Dec 31, 2022
($2.13M)
Feb 9, 2024
Q1
2024
Sep 30, 2022
($1.22M)
Nov 8, 2023
Q3
2023
Mar 31, 2022
($1.34M)
May 11, 2023
Q2
2023
Dec 31, 2021
($3.47M)
Feb 14, 2023
Q1
2023
Sep 30, 2021
($1.44M)
Nov 14, 2022
Q3
2022
Mar 31, 2021
($3.14M)
May 16, 2022
Q2
2022
Dec 31, 2020
($917.3K)
Feb 11, 2022
Q1
2022
Sep 30, 2020
($663.0K)
Nov 12, 2021
Q3
2021
Mar 31, 2020
($28.8K)
May 13, 2021
Q2
2021
Dec 31, 2019
($1.70M)
Feb 12, 2021